A fatty liver often remains undetected, but can develop into a metabolic dysfunctional steatohepatitis (mash). Complications such as cirrhosis, hepatocellular carcinoma (HCC) And often systemic diseases can follow. Those affected particularly often die from cardiovascular diseases. The following case illustrates how important a consistent, interdisciplinary management is.
Crystal light/stock.adobe.com
A 59-year-old man with obesity, dyslipidemia and arterial hypertension visited the oncological consultation of the General Hospital Massachusett. There was one with a semi -annual screening Hepatocellular carcinoma have been discovered. His family doctor had already found increased transaminases 12.5 years earlier during a routine examination.
Since other laboratory values remained unobtrusive, the patient was symptom -free and did not consume alcohol, the family doctor suspected one Metabolic associated steatosis of the liver (Masld).
Three years later, an upper abdominal sonography showed a normal -sized liver with a heterogeneous parenchyma, splenomegaly and prominent vessels on the spleen hilus that pointed out on varices. A gastroenterological examination confirmed the suspicion of chronic liver disease.
The patient had an enlarged liver, Spider-Nävi and a heterogeneous liver texture that indicated a fatty liver. Splenomegaly and varices also indicated cirrhosis.
